Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Risk adjusted net present value: What is the current valuation of Kyowa Kirin's Rocatinlimab?
Rocatinlimab is a monoclonal antibody commercialized by Kyowa Kirin, with a leading Phase III program in Atopic Dermatitis (Atopic Eczema)....
Mogamulizumab by Kyowa Kirin for Peripheral T-Cell Lymphomas (PTCL): Likelihood of Approval
Mogamulizumab is under clinical development by Kyowa Kirin and currently in Phase I for Peripheral T-Cell Lymphomas (PTCL). According to...
Rocatinlimab by Kyowa Kirin for Atopic Dermatitis (Atopic Eczema): Likelihood of Approval
Rocatinlimab is under clinical development by Kyowa Kirin and currently in Phase III for Atopic Dermatitis (Atopic Eczema). According to...
Tivozanib by Kyowa Kirin for Diabetic Macular Edema: Likelihood of Approval
Tivozanib is under clinical development by Kyowa Kirin and currently in Phase II for Diabetic Macular Edema. According to GlobalData,...
Tivozanib by Kyowa Kirin for Wet (Neovascular / Exudative) Macular Degeneration: Likelihood of Approval
Tivozanib is under clinical development by Kyowa Kirin and currently in Phase II for Wet (Neovascular / Exudative) Macular Degeneration....
Rocatinlimab by Kyowa Kirin for Asthma: Likelihood of Approval
Rocatinlimab is under clinical development by Kyowa Kirin and currently in Phase II for Asthma. According to GlobalData, Phase II...
KK-2269 by Kyowa Kirin for Solid Tumor: Likelihood of Approval
KK-2269 is under clinical development by Kyowa Kirin and currently in Phase I for Solid Tumor. According to GlobalData, Phase...
Mogamulizumab by Kyowa Kirin for Oral Cancer: Likelihood of Approval
Mogamulizumab is under clinical development by Kyowa Kirin and currently in Phase I for Oral Cancer. According to GlobalData, Phase...
Mogamulizumab by Kyowa Kirin for Adenocarcinoma Of The Gastroesophageal Junction: Likelihood of Approval
Mogamulizumab is under clinical development by Kyowa Kirin and currently in Phase I for Adenocarcinoma Of The Gastroesophageal Junction. According...